BLU-285

/Tag:BLU-285

It’s a Journey: Our Experience on Clinical Trials

By Jennifer Moore, LRG MemberI was waiting in line to pick up a new prescription for Gleevec when my husband ran in and told me to forget it. After two surgeries, a year on 400 [...]

By | 2018-07-30T10:26:09+00:00 December 28th, 2017|Clinical Trials, Member Stories, News, Newsletter|

GIST Patient Community Update on BLU-285 Clinical Program

Dr. Anthony Boral, Chief Medical Officer of Blueprint Medicines, provided an update on the clinical development of BLU-285, an investigational medicine being developed for patients with advanced GIST. The presentation included an update on [...]

By | 2018-07-18T09:42:26+00:00 July 6th, 2017|Clinical Trials, Webcast|

Update on Blueprint Medicines Clinical Trial for BLU-285

Recently a number of companies have begun to develop therapeutic options that target some of the rarer mutations in GIST. As there are currently no approved treatments specifically for these patients, this [...]

By | 2018-06-12T11:25:27+00:00 May 24th, 2016|Clinical Trials, News, Research|

Recent Posts

Upcoming Events

  1. Sarcoma & GIST: Education Symposium

    September 29 @ 9:00 AM - 2:45 PM
  2. Michigan GDOL 2018

    Michigan GDOL 2018

    October 27 @ 8:00 AM - 3:00 PM
  3. NTFC

    Night to Fight Cancer

    November 7 @ 6:00 PM - 11:00 PM